Mechanistic target of rapamycin complex 2 protein (mTORC2)

Mechanistic target of rapamycin complex 2 protein (mTORC2) is a multi-protein signaling complex primarily formed around the catalytic serine/threonine-protein kinase mTOR, together with core scaffolding and regulatory subunits including Rictor, SIN1, mLST8, Protor1/2, and DEPTOR[1][5][7]. Unlike mTOR complex 1 (mTORC1), mTORC2 is acutely insensitive to the inhibitor rapamycin and is chiefly activated by growth factors and nutrient signaling. It regulates essential cellular processes such as survival, proliferation, metabolism, cytoskeletal dynamics, and autophagy, mostly through phosphorylation of key downstream kinases in the AGC family (like Akt, PKC, and SGK1)[3][5][6]. Aberrant mTORC2 activation or genetic alterations contribute to the pathogenesis of a broad range of diseases, notably cancers, metabolic disorders, neurological conditions, and resistance to therapy[3][5][6]. mTORC2 is considered a high-value therapeutic target, with ongoing research focused on developing and refining inhibitors that can modulate its specific activity[3][5].

Other names

mTOR complex 2mTORC2Mammalian target of rapamycin complex 2mechanistic target of rapamycin complex 2Rictor-mTOR complex

Inhibition of kinase activity (prevents phosphorylation of downstream targets like Akt, PKC, SGK1) Disruption of complex assembly (some agents target interaction domains) Downregulation of signal transduction in cell proliferation and survival pathways